JP2004528089A - メラニン細胞刺激ホルモン（ｍｓｈ）を含む生体適合材料および形成方法 - Google Patents

メラニン細胞刺激ホルモン（ｍｓｈ）を含む生体適合材料および形成方法 Download PDF

Info

Publication number
JP2004528089A
JP2004528089A JP2002580977A JP2002580977A JP2004528089A JP 2004528089 A JP2004528089 A JP 2004528089A JP 2002580977 A JP2002580977 A JP 2002580977A JP 2002580977 A JP2002580977 A JP 2002580977A JP 2004528089 A JP2004528089 A JP 2004528089A
Authority
JP
Japan
Prior art keywords
msh
vehicle
vehicle according
receptor ligand
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002580977A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004528089A5 (enExample
Inventor
シェイラ マクネイル，
ロブ ショート，
クリス ハンター，
ジョン ヘイコック，
ニック ウィリアム，
トニー ライアン，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Sheffield
Original Assignee
University of Sheffield
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0109348A external-priority patent/GB0109348D0/en
Priority claimed from GB0109347A external-priority patent/GB0109347D0/en
Application filed by University of Sheffield filed Critical University of Sheffield
Publication of JP2004528089A publication Critical patent/JP2004528089A/ja
Publication of JP2004528089A5 publication Critical patent/JP2004528089A5/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/6425—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a receptor, e.g. CD4, a cell surface antigen, i.e. not a peptide ligand targeting the antigen, or a cell surface determinant, i.e. a part of the surface of a cell
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Botany (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
JP2002580977A 2001-04-17 2002-04-17 メラニン細胞刺激ホルモン（ｍｓｈ）を含む生体適合材料および形成方法 Withdrawn JP2004528089A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0109348A GB0109348D0 (en) 2001-04-17 2001-04-17 Vehicle
GB0109347A GB0109347D0 (en) 2001-04-17 2001-04-17 Vehicle
PCT/GB2002/001713 WO2002083176A2 (en) 2001-04-17 2002-04-17 Biomaterials comprising a melanocyte stimulating hormone (msh), and method of forming

Publications (2)

Publication Number Publication Date
JP2004528089A true JP2004528089A (ja) 2004-09-16
JP2004528089A5 JP2004528089A5 (enExample) 2005-07-21

Family

ID=26245979

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002580977A Withdrawn JP2004528089A (ja) 2001-04-17 2002-04-17 メラニン細胞刺激ホルモン（ｍｓｈ）を含む生体適合材料および形成方法

Country Status (5)

Country Link
US (1) US20040161443A1 (enExample)
EP (1) EP1381394A2 (enExample)
JP (1) JP2004528089A (enExample)
CA (1) CA2444518A1 (enExample)
WO (1) WO2002083176A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090232866A1 (en) * 2003-10-07 2009-09-17 Mariann Pavone-Gyongyosi Oligopeptides as coating material for medical products
US7858108B2 (en) * 2003-10-21 2010-12-28 Richard Nagler Elutable surface coating
JP2006068378A (ja) * 2004-09-03 2006-03-16 Terumo Corp 血管内留置物
GB2448153B (en) * 2007-04-04 2011-12-28 Camstent Ltd Mbe Coated medical devices
GB2498356B (en) 2012-01-11 2016-09-07 Camstent Ltd Calixarene-derived coatings for implantable medical devices
US20140088381A1 (en) * 2012-09-26 2014-03-27 Google Inc. Facilitation of tear sample collection and testing using a contact lens
WO2018201002A1 (en) * 2017-04-28 2018-11-01 The Schepens Eye Research Institute, Inc. Methods and compositions for reducing corneal endothelial cell loss

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3502099A1 (de) * 1985-01-23 1986-08-07 Dieter Prof. Dr. Dr. 5883 Kierspe Aderhold Therapeutisches, peptid- und/oder aminosaeurehaltiges mittel
FR2691465B1 (fr) * 1992-05-25 1995-08-11 Pf Medicament Complexes comprenant au moins un peptide derive de l'alpha msh, peptide, microsphere, medicament et composition galenique les comprenant.
FR2735131B1 (fr) * 1995-06-12 1997-08-22 Rech De Pathologie Appliquee S Conjugues d'msh avec un acide gras, leur procede de preparation et leur utilisation a titre de medicament
AU6242298A (en) * 1997-01-17 1998-08-07 Celadon Science, Llc Methods for promoting healing of corneal resurfacing wounds
US20020037566A1 (en) * 1997-04-16 2002-03-28 Rees Riley S. Cell-coated supports
TW577759B (en) * 1997-04-18 2004-03-01 Ipsen Pharma Biotech Sustained release compositions in the form of microcapsules or implants and the process for their preparation
GB9914616D0 (en) * 1999-06-23 1999-08-25 Univ Sheffield Attachment surface
AU7593001A (en) * 2000-07-14 2002-01-30 Zycos Inc Alpha-msh related compounds and methods of use

Also Published As

Publication number Publication date
WO2002083176A2 (en) 2002-10-24
US20040161443A1 (en) 2004-08-19
WO2002083176A8 (en) 2002-11-28
WO2002083176A3 (en) 2003-08-14
EP1381394A2 (en) 2004-01-21
CA2444518A1 (en) 2002-10-24

Similar Documents

Publication Publication Date Title
Shin et al. Tissue-adhesive chondroitin sulfate hydrogel for cartilage reconstruction
CA2721507C (en) Methods of generating and using procollagen
JP4503825B2 (ja) 生物学的組織において癒着の形成を防止するための方法および組成物
Dienes et al. Semisynthetic hyaluronic acid-based hydrogel promotes recovery of the injured tibialis anterior skeletal muscle form and function
AU773914B2 (en) Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups
CA2239775C (en) Crosslinked polymer compositions and methods for their use
US5827735A (en) Pluripotent mesenchymal stem cells and methods of use thereof
Yang et al. Cell-mediated delivery of glucocorticoids from thiol-ene hydrogels
WO2014104981A1 (en) Self-assembled ultrashort peptides hydrogels for wound healing, skin care and cosmetics applications
JP2009508991A (ja) ポリマー組成物ならびにその作製方法および使用方法
US20050282747A1 (en) Methods and compositions for wound healing
Luong et al. In situ functionalization of poly (hydroxyethyl methacrylate) cryogels with oligopeptides via β-cyclodextrin–adamantane complexation for studying cell-instructive peptide environment
Pinese et al. Bioactive peptides grafted silicone dressings: A simple and specific method
JP2011125351A (ja) 細胞培養のための表面
JP2004528089A (ja) メラニン細胞刺激ホルモン（ｍｓｈ）を含む生体適合材料および形成方法
Zhang et al. Photo-induced universal modification of small-diameter decellularized blood vessels with a hemocompatible peptide improves in vivo patency
CN108472413A (zh) 包含蛋白质-聚合物缀合物的无有机溶剂组合物及其用途
WO2003030925A1 (fr) Medicaments d'angiogenese
WO2004100934A1 (fr) Implant injectable de globine insoluble
AU2002251276A1 (en) Biomaterials comprising a melanocyte stimulating hormone (MSH), and method of forming
JP2007146178A (ja) キトサン誘導体及び架橋キトサン
JP2004528089A5 (enExample)
JP2007512419A (ja) 生物適合性重合促進剤
KR101775479B1 (ko) 생리활성 온도 감응형 중합체 및 이의 3 차원 세포배양 및 조직공학으로의 용도
Tseng EFFECTS OF POLYMER COMPOSITIONS AND SCAFFOLD SURFACE FUNCTIONALIZATION ON WOUND HEALING

Legal Events

Date Code Title Description
A300 Application deemed to be withdrawn because no request for examination was validly filed

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20050705